glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with losartan potassium in 1 studies
| Studies (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Trials (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Studies (losartan potassium) | Trials (losartan potassium) | Recent Studies (post-2010) (losartan potassium) |
|---|---|---|---|---|---|
| 162 | 1 | 20 | 24,390 | 2,493 | 5,408 |
| Protein | Taxonomy | glycyl-arginyl-glycyl-aspartyl-seryl-proline (IC50) | losartan potassium (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 8.53 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0049 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
| 5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0082 | |
| Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobos, G; Gawaz, MP; Gurland, HJ; Mujais, SK; Schollmeyer, P; Späth, M | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and losartan potassium
| Article | Year |
|---|---|
Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Antibodies, Monoclonal; Epitopes; Erythropoietin; Female; Fibrinogen; Flow Cytometry; Hemorrhagic Disorders; Humans; Kidney Failure, Chronic; Male; Molecular Sequence Data; Oligopeptides; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Binding; Protein Conformation; Recombinant Proteins; Renal Dialysis; Tetradecanoylphorbol Acetate | 1994 |